论文部分内容阅读
目的研制及考评肝癌患者生存质量测定量表。方法采用选题小组和议题小组的程序化决策方式制定量表，并随机抽取１０５例肝癌患者进行测定，以对量表进行考评。结果（１）躯体、心理、症状／副作用、社会功能四个领域以及量表总分的重测信度分别为：０．７６、０．９６、０．７１、０．８０和０．８４：四个领域的内部一致性系数分别为０．７８、０．８１、０．７５和０．６８；（２）量表的结构与概念构思相符，参照于ＦＬＩＣ和ＳＦ－３６两个量表的效标效度分别为０．７６和０．６５；（３）量表能敏感地反应治疗前后生存质量的变化。结论本文研制的量表具有较好的信度、效度和反应度，因而有一定的实用价值
Objective To develop and evaluate the quality of life questionnaire for liver cancer patients. Methods A scale was developed using the programmatic decision-making method of the selected topic group and the topical group, and 105 patients with liver cancer were randomly selected for measurement to evaluate the scale. Results (1) The test-retest reliability of the four areas of physical, psychological, symptom/side effects, social function, and scale total score were: 0.76, 0.96, 0.71, 0.80, and 0.84: The internal consistency coefficients of the four areas were 0.78, 0.81, 0.75, and 0.68, respectively; (2) The structure of the scale was consistent with the conception of the concept, referring to the two scales FLIC and SF-36. The validity of the criteria was 0.76 and 0.65 respectively; (3) The scale could sensitively reflect the changes in quality of life before and after treatment. Conclusion The scale developed in this paper has good reliability, validity and response, so it has a certain practical value.